TargEDys, a Paris, France-based developer of innovative microbiome-based solutions to regulate the appetite, has raised an additional €3.5m in Series A funding. Zaluvida made the investment which supplements the initial €5.8m raised in April 2016, and its non-dilutive funding of €1.1m by Bpifrance in March 2017. The company intends to use the funds to accelerate [...]